Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-01 @ 11:27 AM
Study NCT ID:
NCT01052194
Status:
COMPLETED
Last Update Posted:
2012-12-13
First Post:
2010-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-18
First Submit QC Date:
None
Study First Post Date:
2010-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-12-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-12-12
Last Update Post Date:
2012-12-13
Last Update Post Date Type:
ESTIMATED